WILMINGTON, Del., Jan. 25, 2016 -- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against Amphenol Corporation (“Amphenol” or the “Company”).
If you currently own shares of Amphenol and want to receive additional information and protect your investments free of charge, please visit us at http://www.andrewsspringer.com/cases-investigations/amphenol-class-action-investigation or contact Craig J. Springer, Esq. at [email protected], or call toll free at 1-800-423-6013. You may also follow us on LinkedIn – www.linkedin.com/company/andrews-&-springer-llc, Twitter – www.twitter.com/AndrewsSpringer or Facebook - www.facebook.com/AndrewsSpringer for future updates.
Andrews & Springer is a boutique securities class action law firm representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty or corporate misconduct. Having formerly defended some of the largest financial institutions in the world, our founding members use their valuable knowledge, experience, and superior skill for the sole purpose of achieving positive results for investors. These traits are the hallmarks of our innovative approach to each case our Firm decides to prosecute. For more information please visit our website at www.andrewsspringer.com. This notice may constitute Attorney Advertising.
Contact: Craig J. Springer, Esq. [email protected] Toll Free: 1-800-423-6013


China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business
Ukrainian Drone Makers Target Japan and Asia Defense Market
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation
JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million
US Raises Concerns Over Possible ASML EUV Machine Transfer to China
Obayashi to Acquire Multiplex in $526M Expansion Deal
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks
Trump Says Anthropic No Longer Seen as National Security Threat
SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 



